Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Lifevantage Corporation(LFVN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LFVN
11/02/2026: LFVN (1-star) is currently NOT-A-BUY. Pass it for now.
Lifevantage Corporation is a direct-selling company specializing in nutraceuticals and skincare, anchored by its flagship Protandim supplement. Its primary strengths lie in high gross margins and a lean operating model, which has historically allowed for consistent capital returns to shareholders. The growth story centers on digital transformation efforts to modernize its distributor network and potential expansion into new international territories. However, the company faces significant risks from intense competition, regulatory oversight of the multi-level marketing model, and revenue concentration. This stock may suit dividend-oriented or value-conscious investors, though potential shareholders should monitor distributor growth metrics and regulatory developments closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company operates in a mature niche where growth is currently constrained by industry headwinds. |
| Momentum investor | Weak fit | The stock lacks the consistent upward price momentum required for this style. |
| Value investor | Strong fit while signal remains positive | The stock is often priced at low multiples, making it potentially attractive to value-oriented investors. |
| Dividend investor | Strong fit | The company has a history of returning capital, which may appeal to those seeking steady income. |
| Low-risk investor | Weak fit | The direct-selling business model is inherently volatile and sensitive to regulatory and recruiting risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock can experience sharp price swings based on distributor recruitment data. |
| Valuation risk | Low | The company often trades at modest valuations relative to its earnings potential. |
| Competition risk | High | The crowded supplement market puts constant pressure on market share. |
| Business quality | Medium | The business has high gross margins but faces execution risks inherent to direct selling. |
| Dividend income | Medium | Dividend sustainability depends on the company's ability to maintain stable cash flows. |
| Execution risk | High | Success relies heavily on the effectiveness of the independent distributor network. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 76.41% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 11/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 74.03M USD | Price to earnings Ratio 14.7 | 1Y Target Price 7.5 |
Price to earnings Ratio 14.7 | 1Y Target Price 7.5 | ||
Volume (30-day avg) 28.5K shares | Beta 0.71 | 52 Weeks Range 3.81 - 11.62 | Updated Date 11/01/2026 |
52 Weeks Range 3.81 - 11.62 | Updated Date 11/01/2026 | ||
Dividends yield (FY) 3.15% | Basic EPS (TTM) 0.4 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Nutraceuticals | Protandim and other Nrf2-related supplements sold via distributors. | This is the primary revenue engine for the business. |
| Personal Care | TrueScience skincare products marketed for anti-aging. | This segment complements the health-focused supplement business. |
| Geographic Markets | Operations in the US, Japan, and other international regions. | International expansion is a key variable for revenue growth. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-09 | When After Market | Estimate 0.03 | Actual - |
Profitability
Profit Margin 2.78% | Operating Margin (TTM) 3.93% |
Management Effectiveness
Return on Assets (TTM) 6.25% | Return on Equity (TTM) 14.87% |
Valuation
Trailing PE 14.7 | Forward PE 37.45 | Enterprise Value 68.28M | Price to Sales(TTM) 0.41 |
Enterprise Value 68.28M | Price to Sales(TTM) 0.41 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA 7.7 | Shares Outstanding 12.59M | Shares Floating 8.55M |
Shares Outstanding 12.59M | Shares Floating 8.55M | ||
Percent Insiders 13.69 | Percent Institutions 56.87 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.